Bart van den Broek
5 IP cases indexed. Covers patent matters.
Cases Presided Over
5 cases indexed | Page 1 of 1
A. Menarini Diagnostics s.r.l. v.Abbott Diabetes Care Inc.
This UPC Court of Appeal decision addressed an appeal concerning provisional measures related to a CGM patent. The court confirmed its jurisdiction based on the likelihood of damage arising from products intended for UPC Member States. Ultimately, the appeal was rejected, and the Appellants were ordered to pay €200,000 in interim costs to the Respondent. This case reinforces the broad jurisdictional reach of the UPC when infringing goods are marketed within the territory.
ONWARD Medical N.V. v.Niche Biomedical, Inc.
This UPC appellate decision addressed procedural matters in a dispute over neuromodulation systems. While the core infringement appeal was dismissed, the court issued an order regarding provisional costs. The ruling reinforces principles on how non-registered claims can be asserted and clarifies the standards for determining indirect patent use (Verwendungsbestimmung) based on objective evidence. This case is significant for practitioners dealing with procedural hurdles in complex medical device IP litigation.
KEEEX SAS v.ADOBE INC.
This UPC Court of Appeal decision addresses complex jurisdictional challenges raised by multiple respondents against a patent infringement suit. The court ruled that the UPC is incompetent to adjudicate claims concerning alleged infringements occurring outside the EU, specifically naming Switzerland, Spain, the UK, Ireland, Norway, and Poland. Crucially, the claimant failed to meet evidentiary requirements regarding assets within the jurisdiction necessary for certain jurisdictional arguments under Regulation 1215/2012. This case reinforces strict limits on the UPC's international reach.
A. Menarini Diagnostics S.r.l. v.F. Hoffmann- La Roche AG
This UPC appeal case involved an application for interim measures concerning patent EP 1 962 668, filed by Menarini Diagnostics against Roche. After the initial proceedings at the Local Division of Düsseldorf, the parties reached an out-of-court settlement. Consequently, the claimants withdrew their request for provisional relief. The UPC Board of Appeal accepted this withdrawal and terminated the case, highlighting the importance of amicable resolution in complex patent litigation.
bioMérieux UK Limited, bioMérieux Benelux BV, bioMérieux SA, bioMérieux Deutschland GmbH, bioMérieux Portugal, Lda., bioMérieux Italia S.p.A., bioMérieux Austria GmbH v.Labrador Diagnostics LLC
This UPC Court of Appeal decision addressed procedural applications concerning a patent dispute involving bioMérieux and Labrador Diagnostics. The Appellants sought to stay the proceedings based on pending EPO opposition actions and requested an extension of their appeal deadline to align with potential infringement appeals. The court firmly rejected both requests, reiterating the principle that extensions must be exceptional and noting that existing UPC rules provide efficient mechanisms for aligning parallel proceedings.
Facing a similar IP matter?
Arctic Invent is a specialist IP firm with deep litigation expertise across India, EU, US, and UK. Our team uses data-driven strategy to build stronger cases.